24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Medical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:54
From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey
11:21
Mixpanel is here to help gaming companies democratize their data
09:10
Here’s how gaming brands can reach wider audiences: “Never make assumptions!”
09:01
Israel’s gaming sector is 2% of its GDP - so why is the government ignoring it?
More stories
Buzz
Most popular
Daily
Weekly
1
From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey
2
TechAir flights from Israel to New York take off January 21
3
Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?
4
Kaltura CEO: "Just like a missile hit our office, a missile hit us with the IPO"
5
Defense tech is booming—but who will actually win?
More news
Medical
20 stories about Medical
With 76 Corona Cases, Israeli Ministry of Health Expands Restrictions
11.03.20
|
CTech
As the police sets up teams to make sure potential carriers stay at home, gatherings of over 2,000 have been forbidden
Coronavirus: Five Reasons for Optimism
10.03.20
|
Adi Barak and Tamar Tunik
Covid-19 has already spread to 115 countries and territories around the world, but not everything is bleak. Compared to the 2008 crisis, the financial system is more stable; compared to SARS, medical technology is more advanced
Israel’s Health Ministry Takes Action to Stop Hospitals From Being Overrun
05.03.20
|
Adrian Filut and Omri Milman
Low public investment in infrastructure and understaffed hospitals will turn wide-spread coronavirus into a domestic nightmare. To flatten the infection curve, Israel is taking steps that may be among the harshest globally, to the displeasure of its finance ministry
From the Toy Store to the Soccer Game, How Coronavirus Spread in Israel
04.03.20
|
CTech
A shop owner who returned from Italy and went to work for three days has been connected to infections that have already shut down a school and sent 77 soccer spectators into quarantine
Biomed Company CartiHeal Considers a Nasdaq IPO
26.02.20
|
Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
Coronavirus Could Empty the Coffers of the Israeli Health System
25.02.20
|
Adrian Filut
The Israeli Ministry of Health has already been given $16.34 million for virus-related preparations, but that money is coming out of its budget for the rest of 2020
Integer Acquires Medical Device Company Inomec
20.02.20
|
Hagar Ravet
Inomec develops and manufactures a wide array of medical devices, including laparoscopy systems, catheters, devices for brain and head surgery, imaging technology, and veterinary devices
Private Equity Firm Baring Completes $1.2 Billion Lumenis Acquisition
20.02.20
|
Golan Hazani
In November, Calcalist reported the company signed an MoU for Lumenis’ acquisition from London-based XIO Group
Over-the-Counter Drug Prices in Israel are Much Higher Than Overseas
17.02.20
|
Orna Yefet
The Israeli Ministries of Health and Economy summoned OTC drug manufacturers and distributors for meetings after a study found prices are 37% higher on average in Israel
Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns
16.02.20
|
Lilach Baumer
On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%
Teva’s Small Print Gives Rise to Optimism
13.02.20
|
Sophie Shulman
The improvement CEO Kåre Shultz promised is not immediately evident in the drugmaker’s forecast for 2020, but a closer look shows Teva’s new brand drugs are starting to live up to their promise
CureTech’s Cancer-Fighting Dreams End With Insolvency
03.02.20
|
Lital Dobrovitsky
After an acquisition deal with pharmaceutical company InSight fell through in 2018, the company failed to secure further funding
Coronavirus Shockwaves Already Felt in Israel
03.02.20
|
Adrian Filut and Tzally Greenberg
All Israelis returning from China will be subject to a two-week quarantine at home, under the Israeli Health Ministry’s supervision
As a Preemptive Measure, Israel Authorizes Forced Quarantine of Potential Coronavirus Carriers
28.01.20
|
Adrian Filut and Lilach Baumer
No confirmed cases of the pandemic have been recorded in Israel; the number of fatalities in China has now risen to 106
Israel to Establish National Center for Proton Radiation Cancer Therapy
27.01.20
|
Adrian Filut
The Tel Aviv Sourasky Medical Center (Ichilov Hospital) has been chosen to operate the center, the construction of which is estimated at between $50 million and $100 million
Eltivu Wants to Develop an Espresso Machine-Like Device for Cannabis
26.01.20
|
Tzally Greenberg
The Tel Aviv-based startup is currently raising a first $1 million round to take its device from a prototype to a commercial venture
Teva Fights Muddy Reputation With Positive Report
23.01.20
|
Sophie Shulman
Calcalist obtained a report commissioned by the Israeli drugmaker that details its economic contribution to the countries in which it operates
After a Year of Disappointments, the Israeli Cannabis Industry Pins its Hopes on 2020
22.01.20
|
Tzally Greenberg
Calcalist spoke with leading players of the local cannabis industry to see where the wind will blow in the upcoming year
FIMI Makes $25 Million Private Placement in Biomed Company Kamada
22.01.20
|
Tzally Greenberg
Israel-based private equity fund FIMI became the largest shareholder in Nasdaq and Tel Aviv-listed Kamada in November
BioLineRx’s Flagship Pancreas Cancer Drug Receives Orphan Drug Status in Europe
15.01.20
|
Tzally Greenberg
The clinical stage company’s drug received a similar designation in the U.S. last year
Previous Articles
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility